StockerBroker

Maybe a runner

Long
NASDAQ:ENTX   Entera Bio Ltd.
This has news AH that clinical trials have good results. 70% success rate. Went above its previous support of $3.80 from March of 2019 and stayed above that all day. If it bounces of that support in the morning dip, would be an excellent point to buy.

Second resistance level is around $5. If it breaks that before open then that's a clear breakout.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.